KM-819

KM-819 · Kainos Medicine Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for KM-819, covering 2020-04-13 to 2025-03-05. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate Safety and Efficacy of KM-819 in Healthy Adults and Participants with Parkinson's Disease [Phase 2]

See pricing